Browse studies

Find your next paid study

1 recruiting study matching your filters

A Randomized, Open-label, Multicenter, Phase 3 Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)

This is a Phase 3, global, randomized, open-label, multicenter trial designed to evaluate the safety and efficacy of chronic treatment with brelovitug (BJT-778…

Chronic Hepatitis D Infection

Mirum Pharmaceuticals, Inc.NCT07298330